A ddPCR for detecting EZH2 mutations was set; interestingly, in a patient carrying two different mutations in different tumor sites, the analysis of ctDNA revealed both EZH2 genomic aberrations, so demonstrating the optimal representativeness of liquid biopsy [94]. This evidence concerns the gene EZH2 and neoplasm.